PMAM
AMRX icon

Picton Mahoney Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Picton Mahoney Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65K Hold
133
– – ﹤0.01% 1054
2025
Q4 		$1.68K Hold
133
– – ﹤0.01% 991
2025
Q3 		$1K Hold
133
– – ﹤0.01% 862
2025
Q2 		$1K Hold
133
– – ﹤0.01% 735
2025
Q1 		$1K Hold
133
– – ﹤0.01% 708
2024
Q4 		$1K Hold
133
– – ﹤0.01% 606
2024
Q3 		$1K Buy
+133
New +$1.04K ﹤0.01% 598

Other funds holding AMRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Picton Mahoney Asset Management's AMRX Position: Q1 2026 in Review

Picton Mahoney Asset Management held its Amneal Pharmaceuticals (AMRX) position steady in Q1 2026 at 133 shares worth $1.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1054.

Picton Mahoney Asset Management first reported a position in AMRX in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.68K in Q4 2025. 316 funds tracked by Wall St. Rank hold AMRX as of Q1 2026.

  • Picton Mahoney Asset Management held 133 shares of Amneal Pharmaceuticals worth $1.65K as of Q1 2026.
  • Picton Mahoney Asset Management left its Amneal Pharmaceuticals share count unchanged in Q1 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q1 2026, its #1054 holding.
  • Picton Mahoney Asset Management first reported a position in Amneal Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Picton Mahoney Asset Management's Amneal Pharmaceuticals position peaked at $1.68K in Q4 2025.
  • 316 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.